Welcure Pharmaceuticals Private Limited
Pharmaceutical trading and distribution of medical and chemical products.
1986 | Delhi (India) | Active
Welcure Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.53 M
- Company Age 38 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -32.73%
- Profit Growth -85.02%
- Ebitda -62.29%
- Net Worth 9.85%
- Total Assets -56.97%
About Welcure Pharmaceuticals
Welcure Pharmaceuticals Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 1986 and has a history of 38 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.53 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Jain and Sandeep Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1986PTC025186
- Company No.
025186
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 1986
- Date of AGM
04 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Welcure Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Jain  | Director | 21-Aug-1986 | Current |
| Sandeep Jain | Director | 04-Oct-1999 | Current |
Financial Performance of Welcure Pharmaceuticals.
Welcure Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 32.73% decrease. The company also saw a substantial fall in profitability, with a 85.02% decrease in profit. The company's net worth moved up by a moderate rise of 9.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Welcure Pharmaceuticals?
In 2019, Welcure Pharmaceuticals had a promoter holding of 99.84% and a public holding of 0.16%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Akums FoundationSanjeev Jain and Sandeep Jain are mutual person
Akums Drugs And Pharmaceuticals LimitedSanjeev Jain and Sandeep Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Welcure Pharmaceuticals?
Unlock and access historical data on people associated with Welcure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Welcure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welcure Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.